How Do You Value Space Stocks? From Numbers to ETFs
SpaceX went public at over 90x its revenue. Here’s how to read the future value of space stocks, from backlog to ETFs.
What Powers the Space Industry? From Rockets to Data Centers
Rockets caught in midair, crops checked from orbit, satellites fixed by robots. Meet the tech behind the space industry.
How Did Space Become Big Business? A Beginner’s Guide
Space used to be where governments spent money. Reusable rockets changed that. Here’s how space became big business.
Overpriced or Fair? How to Judge an IPO Price, Explained
A 40% discount can still be expensive. IPOs rarely make anyone rich, but you can learn to spot an overpriced deal. We break down valuation, demand, float, and lock-ups, then test them on SpaceX.
Asked for 100 Shares, Got 10? How IPOs Work, Explained
Asked for 100 IPO shares and got 10? Learn how IPOs really work, from the S-1 and bookbuilding to day-one pricing and lock-ups, with simple math using a made-up company.
U.S. Majors Walked Away. Why Is Alaska LNG Moving Again?
U.S. majors walked away from Alaska LNG in 2016. Now Asian buyers are signing on. Who’s paying, who’s buying, and will it make money?
Oceaneering (OII) Analysis — No. 1 in Underwater Robots
Some jobs happen where no diver can go. Oceaneering started as a small diving company in 1964, became the leader in underwater robots, and now maintains U.S. Navy submarine gear. Here’s the full story.
Investing in GLP-1 Obesity Drugs: What to Look For in Practice
Is a great industry always a great investment? We look at what Lilly and Novo are really worth, the risk of relying on one drug, the days stocks swing hardest, and what obesity ETFs actually hold.
Who’s Winning the Obesity Drug War? Novo vs. Lilly, Explained
Wegovy got there first, so why does Lilly lead today? From a 100-year rivalry and the semaglutide patent cliff to pickaxe suppliers and the food industry, here is how the obesity drug race really works.